Cancer Vaccines

2 trials

Sponsors

National Institute of Oncology and Radiobiology (INOR), Center of Molecular Immunology (CIM)

Conditions

Advanced non small cell lung cancerNon-Small Cell Lung Cancer (NSCLC)

Early Phase 1

Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory

Active, not recruitingRPCEC00000279

Center of Molecular Immunology (CIM)Advanced non small cell lung cancer

Start: 2018-07-09Updated: 2026-03-30

Phase 3

Vaxira as adjuvant treatment for non-small cell lung cancer

Active, not recruitingRPCEC00000207

National Institute of Oncology and Radiobiology (INOR)Non-Small Cell Lung Cancer (NSCLC)

Start: 2015-12-20Target: 120Updated: 2026-03-30